Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
LIVER-TARGETED SUBSTANCE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/121370
Kind Code:
A1
Abstract:
The present invention relates to a liver-targeted drug, and therapeutic use thereof for diseases requiring drug action in the liver. In addition, the present invention relates to a method in which a substance having activity with respect to glucagon is used so as to induce targeting of liver tissues or an increase in distribution in liver tissues after in vivo administration.

More Like This:
Inventors:
KIM JUNG KUK (KR)
LEE JONG SUK (KR)
CHOI JAE HYUK (KR)
LEE JONG MIN (KR)
KIM SANG YUN (KR)
Application Number:
PCT/KR2022/021129
Publication Date:
June 29, 2023
Filing Date:
December 22, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANMI PHARM IND CO LTD (KR)
International Classes:
A61K38/16; A61K47/60; A61K47/68; A61P1/16; A61P3/10
Foreign References:
KR20210040818A2021-04-14
KR20170003466A2017-01-09
KR20180002544A2018-01-08
US8703701B22014-04-22
KR20160082482A2016-07-08
KR20150023013A2015-03-04
KR20220009354A2022-01-24
Attorney, Agent or Firm:
HANOL INTELLECTUAL PROPERTY & LAW (KR)
Download PDF: